Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Christoph Wanner"'
Autor:
Nihar R. Desai, Sankar D. Navaneethan, Susanne B. Nicholas, Kevin M. Pantalone, Christoph Wanner, Stefanie Hamacher, Alain Gay, David C. Wheeler
Publikováno v:
Journal of diabetes and its complications, vol 37, iss 4
AimsContemporary patterns of care of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and the adoption of finerenone are not known. The FINE-REAL study (NCT05348733) is a prospective observational study in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74885b81e84665d7ee8df6fb45245a0c
https://escholarship.org/uc/item/5fb525vw
https://escholarship.org/uc/item/5fb525vw
Autor:
Edouard L Fu, Marie Evans, Karin Windahl, Paul Roderick, Christoph Wanner, Friedo W. Dekker, Maciej Szymczak, Claudia Torino, Fergus Caskey, Equal study investigators, Tora Almquist, Nicholas C. Chesnaye, Christiane Drechsler, Kitty J Jager, Gaetana Porto, Gerd Faxén Irving, Maarit Korkeila Lidén, Magdalena Krajewska, Peter Stenvinkel
Publikováno v:
Caskey, F J 2021, ' Patient-reported measures and lifestyle are associated with deterioration in nutritional status in CKD stage 4-5 : the EQUAL cohort study ', Journal of Renal Nutrition . https://doi.org/10.1053/j.jrn.2021.03.006
Journal of renal nutrition, 32(2), 161-169. W.B. Saunders Ltd
Journal of Renal Nutrition, 32(2), 161-169. W B SAUNDERS CO-ELSEVIER INC
Journal of renal nutrition, 32(2), 161-169. W.B. Saunders Ltd
Journal of Renal Nutrition, 32(2), 161-169. W B SAUNDERS CO-ELSEVIER INC
Objective: The aim of this study was to explore the changes in nutritional status before dialysis initiation and to identify modifiable risk factors of nutritional status decline in older adults with advanced renal disease.& nbsp;Design and Methods:
Autor:
Christoph Wanner, Gregorio T. Obrador, Sushrut S. Waikar, Kevin Carroll, Iain C. Macdougall, Rich Davies, Borut Cizman, Scott D. Solomon, David C. Wheeler, Alexander R. Cobitz, Andrzej Wiecek, Vivekanand Jha, Kirsten L. Johansen, Lata Kler, Allison Blackorby, Vlado Perkovic, Ajay K. Singh, Renato D. Lopes, John J.V. McMurray, Amy Meadowcroft
Publikováno v:
Nephrology Dialysis Transplantation. 37:960-972
Background The Anemia Studies in chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that daprodustat is noninferior to comparator epoetin alfa or darbep
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:317-322
Kidney patients age faster and vascular risk factors intensify the process. Lifetime is reduced up to 16 years in patients with diabetes mellitus type 2 and kidney disease. SGLT2 inhibitors play a significant role in maintaining organ function. By in
Autor:
Reinhold Kreutz, Charles J. Ferro, Francesca Mallamaci, Alberto Ortiz, Giuseppe Mancia, Christoph Wanner, Pantelis Sarafidis, Jean-Michel Halimi
Publikováno v:
Journal of Hypertension. 39:1090-1097
Chronic kidney disease (CKD) is a major issue of public health. Hypertension control and use of renin--angiotensin system (RAS) blockers are the cornerstones of treatment for CKD of any cause. However, even under optimal RAS blockade, many individual
Autor:
Michael Cheung, Kamlesh Khunti, Ian H. de Boer, Katherine R. Tuttle, Wasiu A Olowu, Juliana C.N. Chan, M. Luiza Caramori, Tami Sadusky, Sankar D. Navaneethan, David J. Tunnicliffe, Hiddo J.L. Heerspink, Jonathan C. Craig, Amy Earley, Peter Rossing, Erin D. Michos, Sophia Zoungas, Katy G. Wilkens, Marcello Tonelli, Adrian Liew, Christoph Wanner, Lyubov Lytvyn, Martin Howell, Clint Hurst, Nikhil Tandon
Publikováno v:
Kidney International, 98(4), 839-848. ELSEVIER SCIENCE INC
de Boer, I H, Caramori, M L, Chan, J C N, Heerspink, H J L, Hurst, C, Khunti, K, Liew, A, Michos, E D, Navaneethan, S D, Olowu, W A, Sadusky, T, Tandon, N, Tuttle, K R, Wanner, C, Wilkens, K G, Zoungas, S, Lytvyn, L, Craig, J C, Tunnicliffe, D J, Howell, M, Tonelli, M, Cheung, M, Earley, A & Rossing, P 2020, ' Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline : evidence-based advances in monitoring and treatment ', Kidney International, vol. 98, no. 4, pp. 839-848 . https://doi.org/10.1016/j.kint.2020.06.024
de Boer, I H, Caramori, M L, Chan, J C N, Heerspink, H J L, Hurst, C, Khunti, K, Liew, A, Michos, E D, Navaneethan, S D, Olowu, W A, Sadusky, T, Tandon, N, Tuttle, K R, Wanner, C, Wilkens, K G, Zoungas, S, Lytvyn, L, Craig, J C, Tunnicliffe, D J, Howell, M, Tonelli, M, Cheung, M, Earley, A & Rossing, P 2020, ' Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline : evidence-based advances in monitoring and treatment ', Kidney International, vol. 98, no. 4, pp. 839-848 . https://doi.org/10.1016/j.kint.2020.06.024
The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease represents the first KDIGO guideline on this subject. The guideline comes at a time when advances in diabetes technolo
Autor:
Karolina Szummer, Pia Lundman, Christoph Wanner, Tomas Jernberg, Juan Jesus Carrero, Anna Norhammar, Marco Trevisan, Edouard L Fu, Arvid Sjölander
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 7:104-111
Aims Trial evidence indicates that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of cardiovascular (CV) events in patients with diabetes and myocardial infarction (MI). We aimed to expand this observation to routine care s
Autor:
Thomas Forst, Christoph Wanner, Oliver Schnell, Xavier Cos, Eberhard Standl, Francesco Cosentino, Francesco Giorgino, Hiddo J. L. Heersprink, Mikhail Kosiborod
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Cardiovascular Diabetology, 20(1):75. BioMed Central Ltd.
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Cardiovascular Diabetology, 20(1):75. BioMed Central Ltd.
The 6th Cardiovascular Outcome Trial (CVOT) Summit “Cardiovascular and Renal Outcomes 2020” was the first to be held virtually on October 29–30, 2020. As in previous years, this summit served as reference meeting for in-depth discussions on the
Autor:
Stefan Störk, Jonas Schmoee, Markus P. Schneider, Jürgen Floege, Kai-Uwe Eckardt, Turgay Saritas, Jennifer Nadal, Stephan Achenbach, Georg Schlieper, Sebastian Reinartz, Christoph Wanner, Matthias Schmid, Mohamed Marwan
Publikováno v:
Clinical Kidney Journal
Background Epicardial adipose tissue (EAT) exerts cardiopathogenic effects, but the independent association between EAT and cardiovascular (CV) calcification in patients with chronic kidney disease (CKD) remains controversial. We therefore assessed t
Autor:
George L. Bakris, Bernard Zinman, Christoph Wanner, Michaela Mattheus, Silvio E. Inzucchi, Matthew R. Weir, Naveed Sattar, Audrey Koitka-Weber, David Z.I. Cherney, B. Kraus, Maximilian von Eynatten, Hiddo J.L. Heerspink, Ivana Ritter
Publikováno v:
Kidney International, 99(3), 750-762. ELSEVIER SCIENCE INC
Treatment with sodium-glucose co-transporter-2 inhibitors induces an initial 3-5 ml/min/1.73 m(2) decline in estimated glomerular filtration rate (eGFR). Although considered to be of hemodynamic origin and largely reversible, this 'eGFR dip' may caus